Le Lézard
Classified in: Covid-19 virus
Subjects: Contract/Agreement, Product/Service

CPT Medical and Hoowaki® Partner to Tackle National COVID-19 Testing Kit Demand


Two South Carolina-based companies are teaming up to address the national shortage of COVID-19 testing kits. CPT Medical, a surgical pack and kit manufacturing firm that specializes in viral transport media (VTM), and Hoowaki LLC, the developer of a first-of-its-kind injection molded nasopharyngeal swab with large-scale production capability, have announced a dynamic, new partnership. Hoowaki is providing their NP Collection Swab with Hoowaki MICROGRIP® technology to CPT Medical to be packaged along with CPT Medical's VTM. These kits will be used by healthcare systems and laboratories across the country. Both the VTM and Hoowaki NP Collection Swab are FDA-registered products and organizations and are produced to strict CGMP guidelines.

A recently published Harvard study indicated that up to 20 million COVID-19 tests will be needed per day by the end of summer 2020 to adequately meet demand and flatten the disease growth curve. The partnership between CPT Medical and Hoowaki has already led to the daily production of 20,000 kits. By the end of July, 200,000 kits will be produced weekly.

"Quality specimen collection supplies are a crucial component in ensuring that access to testing is available, as there is currently a critical shortage in the nation's supply chain," said Kevin Murdock, founder of CPT Medical. "We are very excited to partner with Hoowaki, and proud that our new kits will be made right here in Greenville, SC."

Each specimen collection kit packaged by CPT Medical includes their VTM and the Hoowaki NP Collection Swab. CPT Medical has become a top producer of the CDC recommended VTM since adding its production to their long-standing manufacturing of customized surgical kits, packs, and standard procedure trays. Currently producing 100,000 tubes of VTM per week, they expect to increase that number to 200,000 per week within a month's time.

Hoowaki, a specialist in microsurface technologies and friction solutions with a 12-year track-record of innovation, adapted its existing technologies to develop the NP Collection Swab. The swab has the advantage of being produced on existing injection molding equipment, enabling production on a scale not currently available with other swabs. The swab's micro-pillars are shown in clinical user tests to meet existing industry-standard products for flexibility and performance. In independent laboratory testing (RT-qPCR Assay) the swab has also been proven equivalent to the industry-standard flocked filament swabs in the collection of patient RNA that is critical for COVID-19 testing.

According to Ralph Hulseman, president of Hoowaki, "Hoowaki ran toward the challenge of COVID-19 because we understood the power and versatility of our friction-based surfaces and recognized how they can improve our communities. Friction helps our swab easily collect and securely store a patient's RNA specimen until it can be placed into a VTM?that's why we are so excited to work with CPT Medical. It's a partnership based on solving the big challenge of meeting testing demand nationwide."

As part of the partnership, Hoowaki is selling hundreds of thousands of NP Collection Swabs to CPT Medical weekly to be included in the specimen collection kits along with the VTM. Both the Hoowaki NP Collection Swab and CPT Medical's VTM are also available for purchase separately from the specimen collection kits.

To learn more about CPT Medical's specimen collection kits healthcare providers can call 866-584-3713 or visit www.cptmed.com. To learn more about Hoowaki's NP Collection Swab visit www.hoowaki.com/covid19-swabs or call Hoowaki LLC at (864) 238-5631 or email [email protected].

About CPT Medical

CPT Medical, Inc., has manufactured surgical custom and standard procedure trays, packs, and kits assembled to fit specific needs and requirements for over 15 years. At CPT, a clinical staff is available to assist with clinical product support, surgical tray review, and analysis. They specialize in joint relationships with IDN's to establish a turnkey in-house surgical pack operation. For more information, please call 866-584-3713 or visit www.cptmed.com.

About Hoowaki

Hoowaki, LLC is a micro surface engineering services and product solutions company that has developed unique micro surface pattern designs, engineering algorithms, software and manufacturing know-how to address major markets. The company's micro surface technology provides grip or slip solutions in the form of films for medical devices, packaging and other industrial and consumer products. Their team includes experienced micro surface engineers, physicists, friction experts, medical device experts, entrepreneurs, inventors and developers. Hoowaki has market deployment partnerships with Havi (packaging) and BvW Holding AG (implanted medical devices). Hoowaki has a broad patent coverage of micro surface technology.


These press releases may also interest you

at 12:31
The WNET Group, home to New York PBS stations THIRTEEN and WLIW; New Jersey's statewide public television network NJ PBS; arts and culture media provider ALL ARTS; and Long Island's only NPR station WLIW-FM are raising the curtain on all things...

at 11:15
The "Pharmaceutical Packaging Market by Type (Bottle, Vial, Blister Pack, Ampoule, Pre-filled Syringe), Material (Plastic [PE, Polyvinyl chloride, PP, PET], Paper, Glass, Metal), Dosage Form (Oral, Parenteral, Topical), End User-Global Forecast"...

at 11:08
Fairmont Schools' preschool program has emerged as a sought-after solution for parents seeking a highly academic early education for their children. Numerous research studies have demonstrated that children who receive robust academic instruction...

at 11:00
The federal and provincial governments are investing over $365,000 to improve ventilation at the Belvedere Heights long-term care home. This was announced by the Honourable Sean Fraser, Minister of Housing, Infrastructure and Communities; the...

at 10:35
Dr. Reddy's Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the fourth quarter and full year ended March 31, 2024. The information mentioned in this release is based...

at 10:30
The "Global Legionella Testing Market: Analysis By Type, By Application, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. The global legionella testing market has...



News published on and distributed by: